Related Experiment Video
Updated: Jun 27, 2026
Collection, Expansion, and Differentiation of Primary Human Nasal Epithelial Cell Models for Quantification of Cilia Beat Frequency
Published on: November 10, 2021
Understanding Australian healthcare provider attitudes towards smart inhalers for paediatric asthma management: a
Natasha E Noble1,2, Lindsey Cooke3,2, Jamie Bryant3,2
1Health Behaviour Research Collaborative, School of Medicine and Public Health, College of Health, Medicine and Wellbeing, The University of Newcastle, Newcastle, New South Wales, Australia Natasha.Noble@newcastle.edu.au.
Objectives:
This study aimed to explore the perceptions of Australian healthcare providers (HCPs) of the usefulness of smart inhalers for children with asthma and considerations for their effective integration into routine care.
Design:
Qualitative descriptive study using semi-structured interviews. A hybrid thematic analysis approach was used to analyse the data.
Setting:
Healthcare services in Australia including general practice, hospitals and Local Health Districts.
Participants:
Eight general practitioners, six paediatric specialists and nine respiratory nurses were recruited using a unique purposive sampling strategy for each HCP group.
Primary And Secondary Outcome Measures:
Perceptions of the facilitators and challenges to the adoption of smart inhalers for childhood asthma management.
Results:
Most HCPs had not previously used smart inhalers. Perceived benefits of smart inhalers included access to objective medication use data to inform asthma treatment decisions and enable opportunities to discuss asthma management with parents and carers. Key facilitators for implementation included evidence of clinical effectiveness, financial incentives (both in terms of subsidised smart inhaler costs for users and reimbursement for HCPs) and integration of smart inhaler data into existing medical record systems. The primary barrier to implementation identified was related to workflow issues, including available resourcing, support and time.
Conclusions:
HCPs expressed generally positive views about the potential of smart inhalers to improve asthma management among children. However, they also identified several practical, logistical and clinical barriers that must be addressed prior to widespread implementation of smart inhalers. Targeted strategies that address these barriers will be essential for successful implementation into routine care.
Related Concept Videos
01:30Asthma-IV: Diagnostic and Management
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
01:23Inhaled Medications
01:30Asthma-IV: Nursing Management
First, in...
01:20Asthma: Pathogenesis and Management
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
01:29Asthma-I: Introduction
01:23Assessment of Respiration
Subjective Assessment: Nurses interview the patient to gather information directly during the subjective assessment. It includes questions about the individual's medical history, medications, and symptoms, focusing on past respiratory conditions like asthma or COPD,...